Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01557608 · ClinicalTrials.gov registry record · NA
Characterization and Treatment of Chemotherapy Neuropathy
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 754
- Enrollment target
NCT01557608 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 754 participants.
The verdict
NCT01557608, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 754 participants
- Enrollment target
Study Summary
Numbness, tingling, and pain in the hands and feet following the administration of chemotherapy (also called chemotherapy-induced neuropathy (CIN)) is a common problem in oncology patients. However, more information is needed on why patients develop neuropathy and how it impacts their mood, ability to function, and their quality of life. In addition, effective treatments for this problem are not available at the present time. This study will be conducted in two parts. In Part 1, patients who have finished chemotherapy and did or did not develop CIN will be evaluated to determine why some patients do and other patients do not develop CIN. In addition, the impact of CIN on patients' mood, function, and quality of life will be evaluated by comparing patients' reports on these important outcome measures. In addition, genetic markers that contribute to or protect against the development of CIN will be evaluated. Part 2 of this study will test the effects of a new treatment called photon stimulation (also called infrared light therapy) compared to placebo treatment to improve sensations in the feet of oncology patients with CIN. Patients who receive the photon stimulation will have greater improvement in sensation in their feet compared with those who do not receive photon stimulation.
Interventions
- PROCEDURE Photon stimulation
- PROCEDURE Placebo treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01557608
The ClinicalTrials.gov registry entry for NCT01557608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 754 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Photon stimulation is the first listed.
NCT01557608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01557608 about?
NCT01557608 is a clinical study titled "Characterization and Treatment of Chemotherapy Neuropathy". Numbness, tingling, and pain in the hands and feet following the administration of chemotherapy (also called chemotherapy-induced neuropathy (CIN)) is a common problem in oncology patients. However, more information is needed on why patients develop neuropathy and how it impacts their mood, ability ...
What is the current status of trial NCT01557608?
This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2012-04. Estimated completion is 2015-12-08.
What interventions are being tested in trial NCT01557608?
The interventions under investigation include: Photon stimulation (PROCEDURE), Placebo treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01557608?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.